Literature DB >> 23385062

Tumor necrosis factor receptor 2-dependent homeostasis of regulatory T cells as a player in TNF-induced experimental metastasis.

Martin Chopra1, Simone S Riedel, Marlene Biehl, Stefanie Krieger, Viktoria von Krosigk, Carina A Bäuerlein, Christian Brede, Ana-Laura Jordan Garrote, Sabrina Kraus, Viktoria Schäfer, Miriam Ritz, Katharina Mattenheimer, Axelle Degla, Anja Mottok, Hermann Einsele, Harald Wajant, Andreas Beilhack.   

Abstract

The cytokine tumor necrosis factor (TNF) has pleiotropic functions both in normal physiology and disease. TNF signals by the virtue of two cell surface receptors, TNF receptor 1 (TNFR1) and TNF receptor 2 (TNFR2). Exogenous TNF promotes experimental metastasis in some models, yet the underlying mechanisms are poorly understood. To study the contribution of host TNFR1 and TNFR2 on tumor cell progression and metastasis, we employed a syngeneic B16F10 melanoma mouse model of lung metastasis combined with in vivo bioluminescence imaging. Treatment of tumor-bearing mice with recombinant human TNF resulted in a significant increase in tumor burden and metastatic foci. This correlated with an increase in pulmonary regulatory CD4(+)/Foxp3(+) T cells. TNF caused an expansion of regulatory T (Treg) cells in vitro in a TNFR2-dependent manner. To assess the contribution of immune cell expression of endogenous TNF and its two receptors on B16F10 metastasis, we generated bone marrow chimeras by reconstituting wild-type mice with bone marrow from different knockout mice. Loss of either TNF or TNFR2 on immune cells resulted in decreased B16F10 metastasis and lower numbers of Treg cells within the lungs of these animals. Selective depletion of Treg cells attenuated metastasis even in conjunction with TNF treatment. We propose a novel mechanism in which TNF activates TNFR2 on Treg cells and thereby expands this immunosuppressive immune cell population. Loss of either TNF or TNFR2 prevents the accumulation of Treg cells and results in a less tolerogenic environment, enabling the immune system to control B16F10 tumor metastasis and growth.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23385062     DOI: 10.1093/carcin/bgt038

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  44 in total

Review 1.  Th17 cells and Tregs: unlikely allies.

Authors:  Xin Chen; Joost J Oppenheim
Journal:  J Leukoc Biol       Date:  2014-02-21       Impact factor: 4.962

2.  Treatment with agonistic DR3 antibody results in expansion of donor Tregs and reduced graft-versus-host disease.

Authors:  Byung-Su Kim; Hidekazu Nishikii; Jeanette Baker; Antonio Pierini; Dominik Schneidawind; Yuqiong Pan; Andreas Beilhack; Chung-Gyu Park; Robert S Negrin
Journal:  Blood       Date:  2015-06-10       Impact factor: 22.113

3.  The diverse roles of the TNF axis in cancer progression and metastasis.

Authors:  Boram Ham; Maria Celia Fernandez; Zarina D'Costa; Pnina Brodt
Journal:  Trends Cancer Res       Date:  2016-01-01

4.  Donor Requirements for Regulatory T Cell Suppression of Murine Graft-versus-Host Disease.

Authors:  Antonio Pierini; Lucrezia Colonna; Maite Alvarez; Dominik Schneidawind; Hidekazu Nishikii; Jeanette Baker; Yuqiong Pan; Mareike Florek; Byung-Su Kim; Robert S Negrin
Journal:  J Immunol       Date:  2015-05-20       Impact factor: 5.422

5.  Serum progranulin irrelated with Breg cell levels, but elevated in RA patients, reflecting high disease activity.

Authors:  Jiaxi Chen; Shuang Li; Jianfeng Shi; Lili Zhang; Jun Li; Shiyong Chen; Chunlong Wu; Bo Shen
Journal:  Rheumatol Int       Date:  2015-10-13       Impact factor: 2.631

6.  Progranulin promotes tumour necrosis factor-induced proliferation of suppressive mouse CD4⁺ Foxp3⁺ regulatory T cells.

Authors:  Ya Hu; Haitao Xiao; Tingchen Shi; Joost J Oppenheim; Xin Chen
Journal:  Immunology       Date:  2014-06       Impact factor: 7.397

Review 7.  TNF activity and T cells.

Authors:  Amit K Mehta; Donald T Gracias; Michael Croft
Journal:  Cytokine       Date:  2016-08-13       Impact factor: 3.861

Review 8.  Immunomodulation of autoimmune arthritis by pro-inflammatory cytokines.

Authors:  Eugene Y Kim; Kamal D Moudgil
Journal:  Cytokine       Date:  2017-04-25       Impact factor: 3.861

9.  Activated CD8+ T cells induce expansion of Vβ5+ regulatory T cells via TNFR2 signaling.

Authors:  Jara J Joedicke; Lara Myers; Aaron B Carmody; Ronald J Messer; Harald Wajant; Karl S Lang; Philipp A Lang; Tak W Mak; Kim J Hasenkrug; Ulf Dittmer
Journal:  J Immunol       Date:  2014-08-06       Impact factor: 5.422

10.  Blockade of TNF-α signaling benefits cancer therapy by suppressing effector regulatory T cell expansion.

Authors:  Li-Yuan Chang; Yung-Chang Lin; Jy-Ming Chiang; Jayashri Mahalingam; Shih-Huan Su; Ching-Tai Huang; Wei-Ting Chen; Chien-Hao Huang; Wen-Juei Jeng; Yi-Cheng Chen; Shi-Ming Lin; I-Shyan Sheen; Chun-Yen Lin
Journal:  Oncoimmunology       Date:  2015-04-16       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.